How HIV-1's genetic material is organized and packaged
RNA binding and packaging by retroviral Gag proteins
['FUNDING_R01'] · OHIO STATE UNIVERSITY · NIH-11187651
This project explores how the HIV-1 virus organizes its genetic material to make new viruses and proteins, which helps us understand how the virus grows.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-11187651 on ClinicalTrials.gov |
What this research studies
We are learning how the HIV-1 virus prepares its genetic instructions, called RNA, to either create new virus particles or produce the proteins it needs to survive. Tiny differences in the RNA's starting point can change its shape and how it functions within the cell. One shape helps the RNA become part of a new virus, while another shape helps it make viral proteins. Understanding these precise mechanisms is key to figuring out how the virus successfully multiplies and spreads.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation but aims to benefit individuals living with HIV-1 by informing future therapeutic strategies.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention would not find direct benefit from participating in this basic science project.
Why it matters
Potential benefit: If successful, this work could reveal new ways to disrupt HIV-1 replication by targeting how the virus handles its genetic material, potentially leading to new treatments.
How similar studies have performed: While the specific mechanism of 1G and 3G RNA differentiation is a newer area, the broader field of understanding HIV-1 RNA packaging has seen significant progress.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUSIER-FORSYTH, KARIN M — OHIO STATE UNIVERSITY
- Study coordinator: MUSIER-FORSYTH, KARIN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus